These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 16310933)
1. Relationship of NKX3.1 and MYC gene copy number ratio and DNA hypomethylation to prostate carcinoma stage. Kindich R; Florl AR; Kamradt J; Lehmann J; Müller M; Wullich B; Schulz WA Eur Urol; 2006 Jan; 49(1):169-75; discussion 175. PubMed ID: 16310933 [TBL] [Abstract][Full Text] [Related]
2. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion. Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105 [TBL] [Abstract][Full Text] [Related]
3. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer. Asatiani E; Huang WX; Wang A; Rodriguez Ortner E; Cavalli LR; Haddad BR; Gelmann EP Cancer Res; 2005 Feb; 65(4):1164-73. PubMed ID: 15734999 [TBL] [Abstract][Full Text] [Related]
4. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Bowen C; Bubendorf L; Voeller HJ; Slack R; Willi N; Sauter G; Gasser TC; Koivisto P; Lack EE; Kononen J; Kallioniemi OP; Gelmann EP Cancer Res; 2000 Nov; 60(21):6111-5. PubMed ID: 11085535 [TBL] [Abstract][Full Text] [Related]
5. Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma. Schulz WA; Elo JP; Florl AR; Pennanen S; Santourlidis S; Engers R; Buchardt M; Seifert HH; Visakorpi T Genes Chromosomes Cancer; 2002 Sep; 35(1):58-65. PubMed ID: 12203790 [TBL] [Abstract][Full Text] [Related]
6. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function. Zheng SL; Ju JH; Chang BL; Ortner E; Sun J; Isaacs SD; Sun J; Wiley KE; Liu W; Zemedkun M; Walsh PC; Ferretti J; Gruschus J; Isaacs WB; Gelmann EP; Xu J Cancer Res; 2006 Jan; 66(1):69-77. PubMed ID: 16397218 [TBL] [Abstract][Full Text] [Related]
7. Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients. Ribeiro FR; Henrique R; Martins AT; Jerónimo C; Teixeira MR Eur Urol; 2007 Jul; 52(1):116-25. PubMed ID: 17070983 [TBL] [Abstract][Full Text] [Related]
8. Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers. Voeller HJ; Augustus M; Madike V; Bova GS; Carter KC; Gelmann EP Cancer Res; 1997 Oct; 57(20):4455-9. PubMed ID: 9377551 [TBL] [Abstract][Full Text] [Related]
9. [The specific expression profile of homeobox gene NKX3.1 mRNA and protein in prostate tissues and its relationship with primary prostate cancer]. Yang GS; Wang YM; Chen ZD Zhonghua Nan Ke Xue; 2006 Feb; 12(2):137-40, 144. PubMed ID: 16519150 [TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization analysis of c-myc amplification in stage TNM prostate cancer in Japanese patients. Sato H; Minei S; Hachiya T; Yoshida T; Takimoto Y Int J Urol; 2006 Jun; 13(6):761-6. PubMed ID: 16834657 [TBL] [Abstract][Full Text] [Related]
11. Functional analysis of NKX3.1 in LNCaP prostate cancer cells by RNA interference. Possner M; Heuser M; Kaulfuss S; Scharf JG; Schulz W; Hermann-Ringert R; Thelen P Int J Oncol; 2008 Apr; 32(4):877-84. PubMed ID: 18360715 [TBL] [Abstract][Full Text] [Related]
12. Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. Kim MJ; Bhatia-Gaur R; Banach-Petrosky WA; Desai N; Wang Y; Hayward SW; Cunha GR; Cardiff RD; Shen MM; Abate-Shen C Cancer Res; 2002 Jun; 62(11):2999-3004. PubMed ID: 12036903 [TBL] [Abstract][Full Text] [Related]
13. [Correlation between hypomethylation of c-myc and c-N-ras oncogenes and pathological changes in human hepatocellular carcinoma]. Shen L; Qui D; Fang J Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):173-6. PubMed ID: 10920889 [TBL] [Abstract][Full Text] [Related]
14. Identification of an inhibitory cis-element in the promoter region of human homeobox gene NKX3.1. Anli J; Pengju Z; Xiaoyan H; Wenwei C; Zhifang L; Feng K; Huiqing Y; Jianye Z Prostate; 2006 Sep; 66(12):1339-46. PubMed ID: 16845664 [TBL] [Abstract][Full Text] [Related]
15. Occurrence of NKX3.1 C154T polymorphism in men with and without prostate cancer and studies of its effect on protein function. Gelmann EP; Steadman DJ; Ma J; Ahronovitz N; Voeller HJ; Swope S; Abbaszadegan M; Brown KM; Strand K; Hayes RB; Stampfer MJ Cancer Res; 2002 May; 62(9):2654-9. PubMed ID: 11980664 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma. Iacopino F; Angelucci C; Lama G; Zelano G; La Torre G; D'Addessi A; Giovannini C; Bertaccini A; Macaluso MP; Martorana G; Sica G Anticancer Res; 2006; 26(3A):1849-54. PubMed ID: 16827116 [TBL] [Abstract][Full Text] [Related]
17. Alterations of C-MYC, NKX3.1, and E-cadherin expression in canine prostate carcinogenesis. Fonseca-Alves CE; Rodrigues MM; de Moura VM; Rogatto SR; Laufer-Amorim R Microsc Res Tech; 2013 Dec; 76(12):1250-6. PubMed ID: 24030851 [TBL] [Abstract][Full Text] [Related]
18. Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis. Ouyang X; DeWeese TL; Nelson WG; Abate-Shen C Cancer Res; 2005 Aug; 65(15):6773-9. PubMed ID: 16061659 [TBL] [Abstract][Full Text] [Related]
19. Expression of Nkx3.1 enhances 17beta-estradiol anti-tumor action in PC3 human prostate cancer cells. Wang P; Liu B; Luo JD; Zhang ZG; Ma Q; Chen ZD Asian J Androl; 2007 May; 9(3):353-60. PubMed ID: 17486276 [TBL] [Abstract][Full Text] [Related]
20. Analysis of NKX3.1 expression in prostate cancer tissues and correlation with clinicopathologic features. Aslan G; Irer B; Tuna B; Yorukoglu K; Saatcioglu F; Celebi I Pathol Res Pract; 2006; 202(2):93-8. PubMed ID: 16413692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]